A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-21
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 140
- Registration Number
- NCT01437982
- Locations
- 🇰🇷
Bausch & Lomb Korea Ltd, Seoul, Korea, Republic of
Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2012-03-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 300
- Registration Number
- NCT01435460
- Locations
- 🇸🇬
Bausch & Lomb Singapore, Singapore, Singapore
Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2014-11-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 12
- Registration Number
- NCT01416272
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 63
- Registration Number
- NCT01416142
- Locations
- 🇺🇸
Bausch & Lomb, Inc., Rochester, New York, United States
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 100
- Registration Number
- NCT01412983
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
A Study to Evaluate a Modified Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 438
- Registration Number
- NCT01391364
- Locations
- 🇺🇸
Bausch & Lomb, Inc., Rochester, New York, United States
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 440
- Registration Number
- NCT01367249
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Safety and Efficacy of a Contact Lens for Daily Disposable Use
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 173
- Registration Number
- NCT01365039
- Locations
- 🇺🇸
Bausch & Lomb, Inc., Rochester, New York, United States
Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 33
- Registration Number
- NCT01330355
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Bridgewater, New Jersey, United States
Study of A New Contact Lens Cleaning and Disinfecting Solution
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 444
- Registration Number
- NCT01318577
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
© Copyright 2024. All Rights Reserved by MedPath